Resultados da busca - Patrick Y Wen

Refinar Resultados
  1. 1
    Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice

    Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice por Ugonma Chukwueke, Patrick Y. Wen

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents

    Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents por David A. Reardon, Patrick Y. Wen

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications

    The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications por Patrick Y. Wen, Roger J. Packer

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Carta
    Salvar na lista
    Na minha lista:
  4. 4
    Imaging in neuro-oncology

    Imaging in neuro-oncology por Hari Nandu, Patrick Y. Wen, Raymond Y. Huang

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    Epidemiology of brain metastases and leptomeningeal disease

    Epidemiology of brain metastases and leptomeningeal disease por Nayan Lamba, Patrick Y. Wen, Ayal A. Aizer

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials

    Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials por Benjamin M. Ellingson, Patrick Y. Wen, Timothy F. Cloughesy

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  7. 7
    Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma

    Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma por Benjamin M. Ellingson, Patrick Y. Wen, Timothy F. Cloughesy

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  8. 8
    Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors

    Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors por Terri S. Armstrong, Patrick Y Wen, Mark R. Gilbert, David Schiff

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  9. 9
    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies por Kathryn Field, Justin T. Jordan, Patrick Y. Wen, Mark Rosenthal, David A. Reardon

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

    Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response por Raymond Y. Huang, Martha R. Neagu, David A. Reardon, Patrick Y. Wen

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  11. 11
    Response criteria for glioma

    Response criteria for glioma por A. Gregory Sorensen, Tracy T. Batchelor, Patrick Y. Wen, Weiting Zhang, Rakesh K. Jain

    Publicado em 2008
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  12. 12
    Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy

    Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy por David A. Reardon, Patrick Y. Wen, Annick Desjardins, Tracy T. Batchelor, James J. Vredenburgh

    Publicado em 2008
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  13. 13
    Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation

    Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation por Ali G. Saad, Edwin P. Alyea, Patrick Y. Wen, Umberto DeGirolami, Santosh Kesari

    Publicado em 2009
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Pros and cons of current brain tumor imaging

    Pros and cons of current brain tumor imaging por Benjamin M. Ellingson, Patrick Y. Wen, Martin J. van den Bent, Timothy F. Cloughesy

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  15. 15
    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients

    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients por Minesh P. Mehta, Patrick Y. Wen, Ryo Nishikawa, David A. Reardon, Katherine B. Peters

    Publicado em 2017
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  16. 16
    A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma

    A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma por Isabel Arrillaga‐Romany, S. Andrew, Joshua E. Allen, Wolfgang Oster, Patrick Y. Wen, Tracy T. Batchelor

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future

    RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future por Patrick Y. Wen, Martin J. van den Bent, Michael A. Vogelbaum, Susan M. Chang

    Publicado em 2023
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Current clinical development of PI3K pathway inhibitors in glioblastoma

    Current clinical development of PI3K pathway inhibitors in glioblastoma por Patrick Y. Wen, E. Q. Lee, David A. Reardon, Keith L. Ligon, W.K. Alfred Yung

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  19. 19
    Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib

    Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib por Elizabeth R. Gerstner, Poe-Jou Chen, Patrick Y. Wen, Rakesh K. Jain, Tracy T. Batchelor, Gregory Sorensen

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology

    The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology por Daniel Cagney, Joohee Sul, Raymond Y. Huang, Keith L. Ligon, Patrick Y. Wen, Brian M. Alexander

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:

Ferramentas de busca: